Figure 5
Figure 5. Effect of the r-hu ADAMTS13 preparations on cerebral hemorrhage and tail bleeding time. (A) Representative unstained coronal brain sections of 1 mouse for each treatment show a lack of hemorrhage in r-hu ADAMTS13-treated mice (derived from HEK 293 and CHO cells). (B) Bleeding time measurements show highly increased bleeding in VWF−/− mice compared with WT mice. All the VWF−/− mice were cauterized at 900 seconds to stop bleeding. r-hu ADAMTS13-treated mice (5 hours) had a bleeding time comparable with WT mice (prepared in HEK cells) or prolonged bleeding time (prepared in CHO cells) but significantly shorter than the VWF−/− mice. n = 8 each group.

Effect of the r-hu ADAMTS13 preparations on cerebral hemorrhage and tail bleeding time. (A) Representative unstained coronal brain sections of 1 mouse for each treatment show a lack of hemorrhage in r-hu ADAMTS13-treated mice (derived from HEK 293 and CHO cells). (B) Bleeding time measurements show highly increased bleeding in VWF−/− mice compared with WT mice. All the VWF−/− mice were cauterized at 900 seconds to stop bleeding. r-hu ADAMTS13-treated mice (5 hours) had a bleeding time comparable with WT mice (prepared in HEK cells) or prolonged bleeding time (prepared in CHO cells) but significantly shorter than the VWF−/− mice. n = 8 each group.

Close Modal

or Create an Account

Close Modal
Close Modal